Amedeo Smart

Free Medical Literature Service


 

Amedeo

Thoracic Surgery

  Free Subscription

Articles published in
Catheter Cardiovasc Interv
    March 2024
  1. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    >> Share

  2. SETO AH, Yau P
    Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
    Catheter Cardiovasc Interv. 2024 Mar 17. doi: 10.1002/ccd.31014.
    >> Share

  3. POOMMIPANIT P, Tashtish N
    The utility of guide catheter extensions (GCE) in coronary interventions and specifically chronic total occlusion (CTO) interventions.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31012.
    >> Share

  4. EL SHERBINI AH, Servito M, Zidan A, Elsherif S, et al
    Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta-analysis.
    Catheter Cardiovasc Interv. 2024 Mar 10. doi: 10.1002/ccd.30985.
    >> Share

  5. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    >> Share

  6. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    >> Share

  7. DENBY K, Zaczkiewicz M, Banthiya S, Mashayekhi K, et al
    Understanding large vessel perforation requiring treatment with covered stent implantation: A case series.
    Catheter Cardiovasc Interv. 2024;103:570-579.
    >> Share

  8. KIEKENAP J, Sun X, Hao Y, Steitz M, et al
    Long-term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model.
    Catheter Cardiovasc Interv. 2024;103:597-606.
    >> Share

  9. PAN W, Zhou D, Hijazi ZM, Qureshi SA, et al
    2024 Statement from Asia expert operators on transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2024;103:660-669.
    >> Share

  10. ALDOSS O, Porayette P, Mohammad Nijres B
    Bilateral Harmony valve placement in branch pulmonary arteries.
    Catheter Cardiovasc Interv. 2024;103:612-617.
    >> Share

  11. UZUN F, Guner A, Demirci G, Ciloglu K, et al
    Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
    Catheter Cardiovasc Interv. 2024;103:511-522.
    >> Share

  12. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    >> Share

  13. CHAUS A, Uretsky BF
    Treating cardiac tamponade due to malignant effusion with percutaneous balloon pericardiotomy: Back to the future.
    Catheter Cardiovasc Interv. 2024;103:682-683.
    >> Share

  14. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    >> Share

  15. PARK WY, Kim GB, Lee SY, Kim AY, et al
    The adaptability of the Pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease.
    Catheter Cardiovasc Interv. 2024;103:587-596.
    >> Share

    February 2024
  16. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    >> Share

  17. ANDREKA J, Sasi V, Toth GG, Ruzsa Z, et al
    Stent graft implantation from distal radial access-A novel way to treat femoral access site complication during transcatheter aortic valve replacement: A case report.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31001.
    >> Share

  18. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    >> Share

  19. MAIANI S, Nardi G, Di Mario C, Meucci F, et al
    Patient-specific computer simulation of transcatheter aortic valve replacement in patients with previous mechanical mitral prosthesis: A case series.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30984.
    >> Share

  20. HASHEM A, Goldsweig AM
    Funny things are everywhere: Combatting geographic disparities in aortic stenosis care.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30971.
    >> Share

  21. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    >> Share

  22. CHEN Y, Xiao Y, Huang R, Jiang F, et al
    Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30970.
    >> Share

  23. WANG Y, Zhai M, Mao Y, Yang T, et al
    Transcatheter tricuspid valve replacement for functional tricuspid regurgitation after left-sided valve surgery: A single-center experience.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30972.
    >> Share

  24. KELLEY BP, Glasco S, Sang CJ 3rd, Yoo B, et al
    To flip or not: Case series of coronary angioplasty in patients with right-sided heart.
    Catheter Cardiovasc Interv. 2024 Feb 12. doi: 10.1002/ccd.30973.
    >> Share

  25. VAN BAKEL PAJ, Ahmed Y, Hou H, Sukul D, et al
    Geographic variation in aortic stenosis treatment and outcomes among Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2024 Feb 8. doi: 10.1002/ccd.30959.
    >> Share

  26. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    >> Share

  27. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    >> Share

  28. SUZUKA Y, Hirano K, Tokuda T, Diaz JP, et al
    JETWING technique: Combination therapy of JETSTREAM(?) and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.
    Catheter Cardiovasc Interv. 2024;103:335-339.
    >> Share

  29. RIVERO-SANTANA B, Jimenez-Valero S, Jurado-Roman A, Galeote G, et al
    The BALTO Registry: Long-term results of percutaneous BALloon pericardioTomy in oncological patients.
    Catheter Cardiovasc Interv. 2024;103:482-489.
    >> Share

  30. BOSCAMP NS, Maschietto N, Porras D
    Transcatheter pulmonary valve replacement in surgically-created double-barrel right ventricular outflow tracts: A single center case-series.
    Catheter Cardiovasc Interv. 2024;103:455-463.
    >> Share

    January 2024
  31. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    >> Share

  32. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    >> Share

  33. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    >> Share

  34. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    >> Share

  35. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    >> Share

  36. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    >> Share

  37. HEATON J, Imburgio S, Dandu S, Johal A, et al
    Geographic variability and operator trends of transcatheter edge-to-edge repair in the United States.
    Catheter Cardiovasc Interv. 2024;103:147-152.
    >> Share

  38. JIN P, Wang Y, Liu Y, Yang J, et al
    Transapical concomitant transseptal transcatheter closure of a giant mitral paravalvular leak under three-dimensional printing guidance.
    Catheter Cardiovasc Interv. 2024;103:243-247.
    >> Share

    December 2023
  39. SAITO T, Kuno T, Ueyama HA, Kampaktsis PN, et al
    Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Dec 29. doi: 10.1002/ccd.30944.
    >> Share

  40. DEMIRCI G, Aslan S, Guner A, Demir AR, et al
    Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30929.
    >> Share

  41. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    >> Share

  42. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    >> Share

  43. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    >> Share

  44. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    >> Share

  45. YANG Y, Chen J, Dong L, Lu Y, et al
    Transcatheter mitral valve replacement with Mi-thos system: First-in-human experience.
    Catheter Cardiovasc Interv. 2023 Dec 9. doi: 10.1002/ccd.30926.
    >> Share

  46. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    >> Share

  47. JIN Q, Long Y, Zhang G, Pan X, et al
    Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2023 Dec 6. doi: 10.1002/ccd.30916.
    >> Share

  48. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    >> Share

  49. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    >> Share

  50. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    >> Share

  51. ORZALKIEWICZ M, Bruno AG, Saia F, Palmerini T, et al
    A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.
    Catheter Cardiovasc Interv. 2023;102:1389-1392.
    >> Share

  52. PELLEGRINI C, Freissmuth M, Rheude T, Graas D, et al
    Implantation depth of balloon-expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events.
    Catheter Cardiovasc Interv. 2023;102:1301-1310.
    >> Share

  53. CURIO J, Khokhar AA, Beneduce A, Mylotte D, et al
    Patient-specific commissural alignment for ACURATE neo2 implantation in degenerated surgical bioprostheses.
    Catheter Cardiovasc Interv. 2023;102:1401-1405.
    >> Share

    November 2023
  54. SCHNEEBERGER Y, Sarwari H, Koll B, Demal TJ, et al
    Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies.
    Catheter Cardiovasc Interv. 2023 Nov 30. doi: 10.1002/ccd.30922.
    >> Share

  55. ALJABBARY TF, Komatsu I, Ochiai T, Fremes SE, et al
    Cusp overlap method for self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Nov 27. doi: 10.1002/ccd.30910.
    >> Share

  56. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    >> Share

  57. ANDROSHCHUK V, Chehab O, Prendergast B, Rajani R, et al
    Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30918.
    >> Share

  58. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    >> Share

  59. SHARMA S, Nakamura M
    Percutaneous treatment of mechanical mitral valve thrombosis.
    Catheter Cardiovasc Interv. 2023 Nov 16. doi: 10.1002/ccd.30900.
    >> Share

  60. SANZ SANCHEZ J, Regazzoli D, Barbanti M, Fiorina C, et al
    Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Nov 13. doi: 10.1002/ccd.30907.
    >> Share

  61. MAJEED H, Blankenship JC
    Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.
    Catheter Cardiovasc Interv. 2023 Nov 10. doi: 10.1002/ccd.30873.
    >> Share

  62. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    >> Share

  63. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    >> Share

  64. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    >> Share

  65. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    >> Share

  66. MCCABE JM, Helmy T
    Balloon-assisted leaflet modification: Gaining momentum with innovative approaches.
    Catheter Cardiovasc Interv. 2023;102:962-963.
    >> Share

  67. ZAHR F, Lantz G
    Bi-cuspid TAVR; bye or buy!
    Catheter Cardiovasc Interv. 2023;102:960-961.
    >> Share

  68. WILLEMEN Y, De Backer O
    Stroke prevention in TAVR: A patient-tailored approach may be needed.
    Catheter Cardiovasc Interv. 2023;102:964-965.
    >> Share

  69. RISSANEN TT, Kleber FX, Scheller B
    Drug-coated balloon angioplasty is a well-established treatment and in everyday use in cathlabs worldwide.
    Catheter Cardiovasc Interv. 2023;102:912-913.
    >> Share

  70. RESTIVO A, Stanzione A, Maffeo D, Buono A, et al
    Ping-pong snaring of a totally dislodged stent across left main ostium: "All is not lost".
    Catheter Cardiovasc Interv. 2023;102:889-891.
    >> Share

  71. TAN BE, Hashem A, Boppana LKT, Mohamed MS, et al
    Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2023;102:919-928.
    >> Share

  72. HERRMANN HC
    Hemodynamics after TAVR matter.
    Catheter Cardiovasc Interv. 2023;102:944-945.
    >> Share

  73. LEONE PP, Regazzoli D, Pagnesi M, Costa G, et al
    Prosthesis-patient mismatch after transcatheter implantation of contemporary balloon-expandable and self-expandable valves in small aortic annuli.
    Catheter Cardiovasc Interv. 2023;102:931-943.
    >> Share

  74. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    >> Share

  75. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    >> Share

  76. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    >> Share

  77. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    >> Share

  78. GORLA R, Tua L, D'Errigo P, Barbanti M, et al
    Incidence and predictors of 30-day and 6-month stroke after TAVR: Insights from the multicenter OBSERVANT II study.
    Catheter Cardiovasc Interv. 2023;102:1122-1131.
    >> Share

  79. CRITCHFIELD DR, Chamberlain RC, Turek JW, Fleming GA, et al
    Hybrid approach to pulmonary vein stenting after Fontan palliation.
    Catheter Cardiovasc Interv. 2023;102:1095-1100.
    >> Share

  80. STEINBERG ZL, Cabalka AK, Balzer DT, Asnes JD, et al
    Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment.
    Catheter Cardiovasc Interv. 2023;102:1078-1087.
    >> Share

  81. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    >> Share

    October 2023
  82. SHIMAMURA J, Takemoto S, Fukuhara S, Miyamoto Y, et al
    Long-term outcomes after transcatheter aortic valve replacement: Meta-analysis of Kaplan-Meier-derived data.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30854.
    >> Share

  83. SAVVOULIDIS P, Nadir AM, Mechery A, Lawton E, et al
    Routine postaccess-closure angiography to detect vascular complications following transfemoral TAVR.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30894.
    >> Share

  84. GEISLER T, Schreieck J, Euper M, Zdanyte M, et al
    Outcomes of patients undergoing edge-to-edge mitral valve repair with the Edwards PASCAL transcatheter valve repair system under conscious sedation.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30866.
    >> Share

  85. WONG N, Fowler D, Lim DS
    Mitral valve-in-valve with 4D intracardiac echocardiography: Procedural and imaging technique.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30897.
    >> Share

  86. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    >> Share

  87. VELAGAPUDI P, Turagam MK
    Utility of rapid atrial pacing before and after transcatheter aortic valve replacement to predict permanent pacemaker implantation: A valuable piece of the puzzle?
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30880.
    >> Share

  88. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    >> Share

  89. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    >> Share

  90. MAGYARI B, Kittka B, Gojak I, Kasza G, et al
    Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30868.
    >> Share

  91. LORIA JRD, Abdelhafez A, Desch S, Thiele H, et al
    Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30860.
    >> Share

  92. NILSSON K, Buccheri S, Lindback J, Sarno G, et al
    External validation of the Netherlands Heart Registration (NHR) prediction model for early mortality after transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30887.
    >> Share

  93. SKALIDIS I, Hamilos M, Petousis S, Kochiadakis G, et al
    Successful closure of transcatheter aortic valve replacement-induced Gerbode defect with valve-in-valve technique: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30882.
    >> Share

  94. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    >> Share

  95. MAURINA M, Chiarito M, Leone PP, Testa L, et al
    Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30853.
    >> Share

  96. WONG N, Lim DS, Yount K, Yarboro L, et al
    Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30879.
    >> Share

  97. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    >> Share

  98. SPILIAS N, Miyasaka R, Kapadia SR, Krishnaswamy A, et al
    A novel method of prosthetic leaflet modification to enable transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30872.
    >> Share

  99. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    >> Share

    September 2023
  100. SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
    Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
    Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
    >> Share

  101. BARRETT CD, Nickel A, Rosenberg MA, Ream K, et al
    PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 21. doi: 10.1002/ccd.30845.
    >> Share

  102. SOUD M, Feit F, Rao S, Bangalore S, et al
    Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30844.
    >> Share

  103. ROTH N, Heidel C, Xu C, Hubauer U, et al
    Restoration of von Willebrand factor after transcatheter aortic valve replacement-A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30841.
    >> Share

  104. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    >> Share

  105. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    >> Share

  106. HOLZAMER A, Bedogni F, van Wyk P, Barwad P, et al
    Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30820.
    >> Share

  107. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    >> Share

  108. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    >> Share

  109. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    >> Share

  110. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    >> Share

  111. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    >> Share

  112. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    >> Share

  113. FIORINA C, Massussi M, Ancona M, Montorfano M, et al
    Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30813.
    >> Share

  114. HOKKEN TW, Wienemann H, Dargan J, Ginkel DV, et al
    Clinical value of CT-derived simulations of transcatheter-aortic-valve-implantation in challenging anatomies the PRECISE-TAVI trial.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30816.
    >> Share

  115. TRIANTAFYLLIS AS, Desmet W, Tonino PAL
    Diagnosing aberrant circumflex artery prior to transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30819.
    >> Share

  116. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    >> Share

    August 2023
  117. KUNA C, Wiedenmayer N, Bradaric C, Presch A, et al
    Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30807.
    >> Share

  118. GUPTA R, Mahmoudi E, Behnoush AH, Malik AH, et al
    Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30808.
    >> Share

  119. HAMADA S, Ueyama H, Aikawa T, Kampaktsis PN, et al
    Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Aug 14. doi: 10.1002/ccd.30806.
    >> Share

  120. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
    Catheter Cardiovasc Interv. 2023 Aug 10. doi: 10.1002/ccd.30798.
    >> Share

  121. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    >> Share

  122. ZAHR F, Chadderdon S
    Long-term results of M-TEER: A mountain of data with gaps to cross.
    Catheter Cardiovasc Interv. 2023;102:400-401.
    >> Share

  123. LONG Y, Li W, Chen S, Li M, et al
    Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study.
    Catheter Cardiovasc Interv. 2023;102:301-309.
    >> Share

    July 2023
  124. GROGER M, Zeiml KP, Schneider LM, Rottbauer W, et al
    Impact of concomitant tricuspid regurgitation on outcome after edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2023 Jul 28. doi: 10.1002/ccd.30787.
    >> Share

  125. ZHENG HJ, Yan CJ, Lin DQ, Cheng YB, et al
    Prognostic impact of new permanent pacemaker implantation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30788.
    >> Share

  126. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    >> Share

  127. ELBADAWI A, Dang AT, Hamed M, Ali A, et al
    Transcatheter edge-to-edge repair for mitral regurgitation using PASCAL or MitraClip.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30772.
    >> Share

  128. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    >> Share

  129. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    >> Share

  130. AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
    Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
    >> Share

  131. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    >> Share

  132. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    >> Share

  133. GHIZZONI G, Ancona MB, Romano V, Bellini B, et al
    Mind the "commissural drop" when crossing the aortic valve!
    Catheter Cardiovasc Interv. 2023 Jul 18. doi: 10.1002/ccd.30763.
    >> Share

  134. NATALIS A, Masson JB, Mansour MJ, Asmar MA, et al
    Correlation between measured and predicted mismatch with valve hemodynamics in transcatheter aortic valve replacement: A sex-based analysis.
    Catheter Cardiovasc Interv. 2023 Jul 14. doi: 10.1002/ccd.30764.
    >> Share

  135. ZAMORANO JL, Appleby C, Benamer H, Frankenstein L, et al
    Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement.
    Catheter Cardiovasc Interv. 2023 Jul 11. doi: 10.1002/ccd.30760.
    >> Share

  136. FAROUK H, Schone D, Witt C, Bayyud H, et al
    Papillary muscle rupture after transcatheter aortic valve implantation: A case report and literature review.
    Catheter Cardiovasc Interv. 2023 Jul 7. doi: 10.1002/ccd.30761.
    >> Share

  137. LANG FM, Mihatov N, Kriegel J, Nazif TM, et al
    Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.
    Catheter Cardiovasc Interv. 2023 Jul 2. doi: 10.1002/ccd.30755.
    >> Share

  138. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    >> Share

    June 2023
  139. BLANKE P, Modine T, Duncan A, Taramasso M, et al
    Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device.
    Catheter Cardiovasc Interv. 2023 Jun 24. doi: 10.1002/ccd.30752.
    >> Share

  140. REZKALLA J, Reddy Y, Nishimura RA, Padang R, et al
    Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30754.
    >> Share

  141. YOKOYAMA H, Ochiai T, Saito S
    Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review.
    Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30751.
    >> Share

  142. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    >> Share

  143. LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
    Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
    Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
    >> Share

  144. AURIGEMMA C, Trani C, D'Errigo P, Barbanti M, et al
    Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
    Catheter Cardiovasc Interv. 2023 Jun 2. doi: 10.1002/ccd.30695.
    >> Share

  145. DE LA TORRE HERNANDEZ JM, Veiga Fernandez G, Barrera S, Sainz Laso F, et al
    Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
    Catheter Cardiovasc Interv. 2023;101:1214-1220.
    >> Share

  146. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    >> Share

  147. MERDLER I, Bernardo NL, Ben-Dor I, Waksman R, et al
    Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
    Catheter Cardiovasc Interv. 2023;101:1235-1238.
    >> Share

    May 2023
  148. WOLFRUM M, Moccetti F, Loretz L, Bossard M, et al
    Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30697.
    >> Share

  149. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    >> Share

  150. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30698.
    >> Share

  151. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    >> Share

  152. HO CB, Vejlstrup NG, De Backer O, Sondergaard L, et al
    Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30694.
    >> Share

  153. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    >> Share

  154. SPARGIAS K, Lim DS, Makkar R, Kar S, et al
    Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.
    Catheter Cardiovasc Interv. 2023 May 13. doi: 10.1002/ccd.30686.
    >> Share

  155. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    >> Share

  156. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    >> Share

  157. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    >> Share

  158. HAMEED I, Ahmed A, Kumar A, Li E, et al
    Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30674.
    >> Share

  159. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    >> Share

  160. CALI F, Pagnesi M, Pezzola E, Montisci A, et al
    Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
    >> Share

  161. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    >> Share

  162. BUCKLEY AJ, Hensey M, O'Connor S, Maree A, et al
    Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices.
    Catheter Cardiovasc Interv. 2023 May 7. doi: 10.1002/ccd.30675.
    >> Share

  163. MUSTAFA U, Helmy T
    TAVR for all-Is it time?
    Catheter Cardiovasc Interv. 2023;101:1174-1175.
    >> Share

  164. FELDMAN D, Cao D, Sartori S, Zhang Z, et al
    Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2023;101:1134-1143.
    >> Share

  165. SAMIMI S, Chavez Ponce A, Alarouri HS, Shaer AE, et al
    Predictors of hemodynamic response to mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023;101:1120-1127.
    >> Share

  166. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    >> Share

  167. YIN J, Wang R, Chen H, Lu H, et al
    In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
    Catheter Cardiovasc Interv. 2023;101:1062-1070.
    >> Share

  168. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    >> Share

    April 2023
  169. YESANTHARAO PS, Etchill EW, Zhou AL, Ong CS, et al
    The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
    Catheter Cardiovasc Interv. 2023 Apr 27. doi: 10.1002/ccd.30670.
    >> Share

  170. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Apr 18. doi: 10.1002/ccd.30666.
    >> Share

  171. HOSSEINI M, Lahr BD, Greason KL, Arghami A, et al
    Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2023 Apr 10. doi: 10.1002/ccd.30658.
    >> Share

  172. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    >> Share

  173. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    >> Share

  174. HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
    Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
    Catheter Cardiovasc Interv. 2023;101:863-869.
    >> Share

    March 2023
  175. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    >> Share

  176. MEIJERINK F, Holierook M, Eberl S, Robbers-Visser D, et al
    Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30645.
    >> Share

  177. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    >> Share

  178. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
    >> Share

  179. HILLEGASS WB
    Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30640.
    >> Share

  180. RYAN N, Alasnag M
    Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
    Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
    >> Share

  181. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    >> Share

  182. ALI N, Hildick-Smith D, Parker J, Malkin CJ, et al
    Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30627.
    >> Share

  183. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    >> Share

  184. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    >> Share

  185. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    >> Share

  186. UEYAMA H, Block PC
    Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?
    Catheter Cardiovasc Interv. 2023;101:830-831.
    >> Share

  187. HEUSER RR
    Regulators can we get DCB balloons approved for use in the United States?
    Catheter Cardiovasc Interv. 2023;101:834-835.
    >> Share

  188. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    >> Share

    February 2023
  189. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    >> Share

  190. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    >> Share

  191. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    >> Share

  192. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    >> Share

  193. SEDHOM R, Dang AT, Elwagdy A, Megaly M, et al
    Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30597.
    >> Share

  194. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    >> Share

  195. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    >> Share

  196. NATANZON SS, Koseki K, Kaewkes D, Koren O, et al
    Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients.
    Catheter Cardiovasc Interv. 2023;101:596-604.
    >> Share

  197. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    >> Share

  198. ERDEM S, An SY, McAlister CA, Basra SS, et al
    Suicide left ventricle following protamine: A case report.
    Catheter Cardiovasc Interv. 2023;101:592-595.
    >> Share

    January 2023
  199. LUGO-FAGUNDO N, Pierre K, Adedinsewo D, Simard T, et al
    The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jan 30. doi: 10.1002/ccd.30577.
    >> Share

  200. ALVAREZ-COVARRUBIAS HA, Joner M, Cassese S, Warmbrunn M, et al
    Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
    Catheter Cardiovasc Interv. 2023 Jan 29. doi: 10.1002/ccd.30576.
    >> Share

  201. HIRUMA T, Higuchi R, Saji M, Takamisawa I, et al
    Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
    Catheter Cardiovasc Interv. 2023 Jan 26. doi: 10.1002/ccd.30574.
    >> Share

  202. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    >> Share

  203. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    >> Share

  204. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    >> Share

  205. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    >> Share

  206. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    >> Share

  207. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies.
    Catheter Cardiovasc Interv. 2023 Jan 19. doi: 10.1002/ccd.30562.
    >> Share

  208. MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
    Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
    >> Share

  209. SAVVOULIDIS P, Nadir AM, Mechery A, Doshi SN, et al
    A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30557.
    >> Share

  210. ISMAYL M, Machanahalli Balakrishna A, Elgayesh MM, Thandra A, et al
    Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549.
    >> Share

  211. CHEN J, Yang Y, Song W, Feng D, et al
    Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30554.
    >> Share

  212. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    >> Share

  213. DOOST A, Chilmeran A, Gomes A, Dworakowski R, et al
    Single arterial access closure of post-infarction ventricular septal defect: A case series.
    Catheter Cardiovasc Interv. 2023;101:209-216.
    >> Share

  214. SHIBBANI K, Aboulhosn J, Levi D, Mohammad Nijres B, et al
    Hybrid approach for harmony transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2023;101:135-139.
    >> Share

  215. BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
    Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
    Catheter Cardiovasc Interv. 2023;101:97-101.
    >> Share

    December 2022
  216. BARBOSA MOREIRA MJ, Peixoto NADA, Udoma-Udofa OC, de Araujo SLS, et al
    Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: A meta-analysis of randomized studies.
    Catheter Cardiovasc Interv. 2022 Dec 27. doi: 10.1002/ccd.30532.
    >> Share

  217. ISOGAI T, Agrawal A, Shekhar S, Spilias N, et al
    One-year clinical and echocardiographic outcomes of transcatheter aortic valve replacement with SAPIEN 3 Ultra versus SAPIEN 3.
    Catheter Cardiovasc Interv. 2022 Dec 13. doi: 10.1002/ccd.30515.
    >> Share

  218. ROUT A, Sharma A, Ikram S, Garg A, et al
    Short-term dual antiplatelet therapy for 1-3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2022 Dec 9. doi: 10.1002/ccd.30521.
    >> Share

  219. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    >> Share

  220. ZAID S, Haniyeh AA, Rosenzveig A, Malik A, et al
    Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation: Incidence and echocardiographic distribution of missed paravalvular regurgitation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30512.
    >> Share

  221. OGAMI T, Kliner DE, Toma C, Serna-Gallegos D, et al
    Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30508.
    >> Share

  222. EL HAJJ M, Krajcer Z
    Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
    Catheter Cardiovasc Interv. 2022;100:1300-1301.
    >> Share

  223. MICHAIL M, Cockburn J, Tanseco KVP, Arunothayaraj S, et al
    Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:1302-1306.
    >> Share

  224. TOMII D, Okuno T, Lanz J, Stortecky S, et al
    Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 1. doi: 10.1002/ccd.30507.
    >> Share

    November 2022
  225. TANNER R, Murphy S, Malone C, McGorrian C, et al
    Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30469.
    >> Share

  226. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    >> Share

  227. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    >> Share

  228. SAMMOUR YM, Lak H, Chahine J, Abushouk A, et al
    Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30488.
    >> Share

  229. BALDUS S, Schofer N, Hausleiter J, Friedrichs K, et al
    Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30450.
    >> Share

  230. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    >> Share

  231. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    >> Share

  232. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    >> Share

  233. MEREDITH T, Scheuer S, Hoffman M, Joshi Y, et al
    Coronary angiography of the ex-situ beating donor heart in a portable organ care system.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30455.
    >> Share

  234. MILLER MS, Cutts J, Donatelle M, Shah K, et al
    Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30471.
    >> Share

  235. ABDULLA A, Jneid H
    Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
    Catheter Cardiovasc Interv. 2022;100:901-902.
    >> Share

  236. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    >> Share

  237. NARAYANAN A, Jneid H
    A new frontier in left atrial appendage closure.
    Catheter Cardiovasc Interv. 2022;100:929-930.
    >> Share

  238. UEYAMA H, Block PC
    Membranous septum length may not be the answer.
    Catheter Cardiovasc Interv. 2022;100:877-878.
    >> Share

  239. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    >> Share

  240. SATLER LF
    When possible, try to avoid emergent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;100:839-840.
    >> Share

  241. TAYLOR A, Yang J, Dubin A, Chubb MH, et al
    Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device.
    Catheter Cardiovasc Interv. 2022;100:766-773.
    >> Share

  242. CHAVARRIA J, Falcao F, Dutra G, Sathananthan J, et al
    Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;100:823-831.
    >> Share

  243. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    >> Share

  244. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    >> Share

  245. SHAMEKHI J, Hasse C, Veulemans V, Al-Kassou B, et al
    A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR-A multicenter analysis.
    Catheter Cardiovasc Interv. 2022;100:850-859.
    >> Share

  246. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    >> Share

  247. UEYAMA H, Block PC
    Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
    Catheter Cardiovasc Interv. 2022;100:1132-1133.
    >> Share

  248. SALAETS T, Cools B, De Meester P, Heying R, et al
    Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
    Catheter Cardiovasc Interv. 2022;100:1059-1066.
    >> Share

  249. NAGASAKA T, Amanai S, Ishibashi Y, Aihara K, et al
    Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;100:971-978.
    >> Share

  250. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    >> Share

  251. PICCOLO R, Esposito G
    Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100:1146-1147.
    >> Share

  252. SETH A, Ezhumalai B
    Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
    Catheter Cardiovasc Interv. 2022;100:1148-1149.
    >> Share

  253. ALLANA SS, Brilakis ES
    Why complex and high risk percutaneous coronary interventions should be offered to selected octogenarians/nonagenarians.
    Catheter Cardiovasc Interv. 2022;100:1143-1145.
    >> Share

  254. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    >> Share

  255. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    >> Share

  256. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    >> Share

    October 2022
  257. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    >> Share

  258. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    >> Share

  259. TEBAR MARQUEZ D, Moreno R, Galeote G, Jurado-Roman A, et al
    Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30449.
    >> Share

  260. GERCEK M, Irimie AA, Gercek M, Fox H, et al
    Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30443.
    >> Share

  261. YASHIGE M, Zen K, Takamatsu K, Matoba S, et al
    Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30444.
    >> Share

  262. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    >> Share

  263. VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
    Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
    Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
    >> Share


  264. Erratum to "Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience".
    Catheter Cardiovasc Interv. 2022 Oct 4. doi: 10.1002/ccd.30409.
    >> Share

  265. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    >> Share

  266. EARLE W, Abdallah G, Meagher S, Shen K, et al
    Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
    >> Share

  267. ULLAH W, Zahid S, Muhammadzai H, Khalil F, et al
    Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30407.
    >> Share

  268. KHOKHAR AA, Giannini F, Zlahoda-Huzior A, Mikhail G, et al
    Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.
    Catheter Cardiovasc Interv. 2022;100:662-666.
    >> Share

  269. ZABLAH JE, Dohlen G, Ystgaard MB, Morgan GJ, et al
    Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2022;100:606-611.
    >> Share

  270. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    >> Share

    September 2022
  271. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    >> Share

  272. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    >> Share

  273. BERKOVITCH A, Segev A, Guetta V, Finkelstein A, et al
    Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30386.
    >> Share

  274. ABUSHOUK AI, Abdelfattah O, Gad MM, Saad A, et al
    Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30388.
    >> Share

  275. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    >> Share

  276. ZAHR F, Chadderdon S, Song H, Sako E, et al
    Contemporary diagnosis and management of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2022 Sep 10. doi: 10.1002/ccd.30364.
    >> Share

  277. HIOKI H, Watanabe Y, Kozuma K, Ryuzaki T, et al
    Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30377.
    >> Share

  278. AL-FARRA H, Ravelli ACJ, Henriques JPS, Houterman S, et al
    Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30398.
    >> Share

  279. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    >> Share

  280. GRINES CL, Dupont A
    Turndown for coronary artery bypass surgery: Never say never to revascularization.
    Catheter Cardiovasc Interv. 2022;100:367-368.
    >> Share

  281. TARANTINI G, Cardaioli F
    SAPIEN 3 transcatheter heart valve in patients with borderline annulus: "stretched better than bigger?"
    Catheter Cardiovasc Interv. 2022;100:422-423.
    >> Share

  282. ZAHID S, Khan MZ, Ullah W, Tanveer Ud Din M, et al
    In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
    Catheter Cardiovasc Interv. 2022;100:424-436.
    >> Share

    August 2022
  283. SAGER R, Keller LS, Stehli J, Jakob P, et al
    Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
    >> Share

  284. MAURINA M, Condello F, Mangieri A, Sanz-Sanchez J, et al
    Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30385.
    >> Share

  285. OKUNO T, Dangas GD, Hengstenberg C, Sartori S, et al
    Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30370.
    >> Share

  286. SADAT N, Bruhn D, Scharfschwerdt M, Schaller T, et al
    Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30359.
    >> Share

  287. ZAJARIAS A, Kodali S, McCabe JM, Eng MH, et al
    Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30331.
    >> Share

  288. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    >> Share

  289. LIU JD, Zhang SY, Wu YQ, Gong R, et al
    Valve implantation for successful sealing of a balloon predilatation-induced annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 3. doi: 10.1002/ccd.30353.
    >> Share

  290. ISOGAI T, Vanguru HR, Krishnaswamy A, Agrawal A, et al
    Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30340.
    >> Share

  291. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    >> Share

  292. ENG MH, Zahr F
    When should early discharge post-transcatheter aortic valve replacement be blocked?
    Catheter Cardiovasc Interv. 2022;100:254-255.
    >> Share

  293. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    >> Share

  294. TARANTINI G, Cardaioli F
    Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.
    Catheter Cardiovasc Interv. 2022;100:243-244.
    >> Share

  295. HELMY T, Mina G
    Single access TAVR. How "minimalist" do we need to be?
    Catheter Cardiovasc Interv. 2022;100:233-234.
    >> Share

    July 2022
  296. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    >> Share

  297. GALLITTO E, Palmerini T, Saia F, Gargiulo M, et al
    Iliac "paving & cracking" technique for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30344.
    >> Share

  298. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    >> Share

  299. DAUTZENBERG L, van Aarle TTM, Stella PR, Emmelot-Vonk M, et al
    The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2022 Jul 13. doi: 10.1002/ccd.30320.
    >> Share

  300. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    >> Share

  301. RUSSO M, Chen C, Sethi A, Hakeem A, et al
    TAVR in an XXXL annulus (1057 mm(2) ) with type I bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325.
    >> Share

  302. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    >> Share

  303. ALASNAG M
    Lifetime management when a redo is in the balance: Valve-in-valve transcatheter aortic valve replacement or resurgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022;100:131-132.
    >> Share

  304. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    >> Share

  305. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    >> Share

  306. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    >> Share

    June 2022
  307. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    >> Share

  308. ELZANATY AM, Maraey A, Elbadawi A, Khalil M, et al
    Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2022 Jun 27. doi: 10.1002/ccd.30299.
    >> Share

  309. MEDRANDA GA, Rogers T, Fuery M, Case BC, et al
    Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.
    Catheter Cardiovasc Interv. 2022 Jun 20. doi: 10.1002/ccd.30301.
    >> Share

  310. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    >> Share

  311. ARONEY NP, Patterson T, Kalogeropoulos A, Allen CJ, et al
    Clinical outcomes following single access transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30246.
    >> Share

  312. ROBERT P, Akodad M, Lattuca B, Gandet T, et al
    Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
    Catheter Cardiovasc Interv. 2022 Jun 5. doi: 10.1002/ccd.30248.
    >> Share

  313. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    >> Share

  314. TARANTINI G, Fraccaro C
    Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters.
    Catheter Cardiovasc Interv. 2022;99:2111-2112.
    >> Share

  315. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    >> Share

    May 2022
  316. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30245.
    >> Share

  317. KLEIN LW, Anderson HV, Cigarroa J
    Integrating shared decision-making in coronary revascularization with quality assurance programs.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
    >> Share

  318. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    >> Share

  319. ALACHKAR MN, Muller T, Alnaimi A, Milzi A, et al
    Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real-world cohort.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30238.
    >> Share

  320. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    >> Share

  321. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    >> Share

  322. CORCIONE N, Berni A, Ferraro P, Morello A, et al
    Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
    >> Share

  323. SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
    Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
    >> Share

  324. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    >> Share

  325. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    >> Share

  326. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    >> Share

  327. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    >> Share

  328. POSTALIAN A, Krajcer Z
    Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
    Catheter Cardiovasc Interv. 2022;99:1817-1818.
    >> Share

  329. TARANTINI G, Cardaioli F
    TAVR and stroke: A common evolution.
    Catheter Cardiovasc Interv. 2022;99:1906-1907.
    >> Share

  330. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    >> Share

  331. SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
    Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Catheter Cardiovasc Interv. 2022;99:1859-1866.
    >> Share

  332. TANG GHL, Hooda A, Zaid S, Chuang MY, et al
    Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Catheter Cardiovasc Interv. 2022;99:1935-1944.
    >> Share

  333. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    >> Share

  334. VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
    Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
    Catheter Cardiovasc Interv. 2022;99:1925-1934.
    >> Share

  335. MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
    Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
    Catheter Cardiovasc Interv. 2022;99:1877-1885.
    >> Share

  336. PORAT A, Gordon M, Perlman G, Planer D, et al
    Mass to voltage ratio index predicts mortality following TAVI.
    Catheter Cardiovasc Interv. 2022;99:1918-1924.
    >> Share

  337. ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
    Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1796-1806.
    >> Share

  338. YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
    Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1819-1828.
    >> Share

  339. ALADIN AI, Case BC, Wermers JP, Rogers T, et al
    Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
    Catheter Cardiovasc Interv. 2022;99:1789-1795.
    >> Share

    April 2022
  340. BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
    Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
    >> Share

  341. MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
    Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
    >> Share

  342. KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
    Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
    >> Share

  343. HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
    Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
    >> Share

  344. BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
    Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
    >> Share

  345. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    >> Share

  346. HOU S, Pan W, Zhou D, Ge J, et al
    Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
    >> Share

  347. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    >> Share

  348. YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
    Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
    >> Share

  349. INCI E, Block PC
    A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022;99:1590-1591.
    >> Share

  350. LIU X, Chen Y, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
    Catheter Cardiovasc Interv. 2022;99:1691-1695.
    >> Share

  351. SEGAR MW, Krajcer Z
    Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
    Catheter Cardiovasc Interv. 2022;99:1645-1646.
    >> Share

  352. TARANTINI G, Rodino G
    Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
    Catheter Cardiovasc Interv. 2022;99:1609-1610.
    >> Share

  353. BRUCE CG, Lederman RJ
    Troubleshooting transcaval access: Honoring our commitments.
    Catheter Cardiovasc Interv. 2022;99:1700-1701.
    >> Share

  354. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    >> Share

  355. RUGE H, Burri M, Erlebach M, Lange R, et al
    Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
    Catheter Cardiovasc Interv. 2022;99:1611-1618.
    >> Share

  356. GOLDSWEIG AM, Hermiller JB
    Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
    Catheter Cardiovasc Interv. 2022;99:1597-1598.
    >> Share

    March 2022
  357. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    >> Share

  358. ZHU Q, Yuan Z, Xu Y, Chen J, et al
    Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
    >> Share

  359. LE RUZ R, Guerin P, Leurent G, Leroux L, et al
    Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
    >> Share

  360. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    >> Share

  361. ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
    Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
    >> Share

  362. SA MP, Jabagi H, Dokollari A, Awad AK, et al
    Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
    >> Share

  363. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    >> Share

  364. ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
    Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
    >> Share

  365. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    >> Share

  366. MANO TB, Ramos R, Cacela D, Patricio L, et al
    Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
    Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
    >> Share

  367. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    >> Share

  368. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    >> Share

  369. GILANI S, Jneid H
    Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:1186-1187.
    >> Share

  370. ENG MH, Fang HK
    Forgotten and unforgiving.
    Catheter Cardiovasc Interv. 2022;99:1287-1288.
    >> Share

  371. SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
    TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2022;99:1181-1185.
    >> Share

  372. FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
    Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1251-1256.
    >> Share

  373. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    >> Share

  374. RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
    Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Catheter Cardiovasc Interv. 2022;99:1268-1276.
    >> Share

  375. BATLIVALA SP, Hagel JA, Hirsch R, Shahanavaz S, et al
    Transcatheter pulmonary valve-in-valve implantation within the expandable Inspiris Resilia(R) bioprosthetic valve.
    Catheter Cardiovasc Interv. 2022;99:1157-1160.
    >> Share

  376. KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
    Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
    Catheter Cardiovasc Interv. 2022;99:1138-1148.
    >> Share

  377. ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
    Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1370-1372.
    >> Share

  378. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    >> Share

    February 2022
  379. ASAMI M, Dobner S, Stortecky S, Heg D, et al
    Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
    >> Share

  380. ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
    Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
    >> Share

  381. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    >> Share

  382. BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
    The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
    >> Share

  383. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    >> Share

  384. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    >> Share

  385. POSTALIAN A, Krajcer Z
    Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
    Catheter Cardiovasc Interv. 2022;99:932-933.
    >> Share

  386. GOLDSWEIG AM, Baron SJ
    Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:904-905.
    >> Share

  387. UPADHYAY A, Jneid H
    Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
    Catheter Cardiovasc Interv. 2022;99:867-868.
    >> Share

  388. O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
    Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
    Catheter Cardiovasc Interv. 2022;99:943-948.
    >> Share

  389. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
    Catheter Cardiovasc Interv. 2022;99:861-866.
    >> Share

  390. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    >> Share

  391. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    >> Share

    January 2022
  392. ZHOU D, Chen J, Fan J, Yidilisi A, et al
    Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
    >> Share

  393. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    >> Share

  394. OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
    Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
    >> Share

  395. PAULUS MG, Meindl C, Hamerle M, Schach C, et al
    Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
    >> Share

  396. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    >> Share

  397. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    >> Share

  398. YUAN S, He J, Cai Z, Zhang R, et al
    Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
    >> Share

  399. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    >> Share

  400. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    >> Share

  401. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    >> Share

  402. KATO N, Pellikka PA, Scott CG, Lee AT, et al
    Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
    >> Share

  403. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    >> Share

  404. SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
    5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
    >> Share

  405. FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
    Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
    >> Share

  406. PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
    Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
    >> Share

  407. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    >> Share

  408. ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
    Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
    >> Share

  409. CHIOU A, Yap J, Russo S, Stripe BR, et al
    Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
    >> Share

  410. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    >> Share

  411. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    >> Share

  412. SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
    Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
    >> Share

  413. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    >> Share

  414. OKUYA Y, Moussa ID
    Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
    Catheter Cardiovasc Interv. 2022;99:169-170.
    >> Share

  415. BELARDI J, Lamelas P
    Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
    Catheter Cardiovasc Interv. 2022;99:179-180.
    >> Share

  416. UPADHYAY A, Jneid H
    Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:158-159.
    >> Share

  417. RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
    Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;99:E38-E42.
    >> Share

  418. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    >> Share

    December 2021
  419. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    >> Share

  420. VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
    Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
    >> Share

  421. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    >> Share

  422. OKOH AK, Chen C, Kassotis J, Soliman F, et al
    Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
    >> Share

  423. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    >> Share

  424. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    >> Share

  425. MOUSSA ID
    Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
    Catheter Cardiovasc Interv. 2021;98:1402-1403.
    >> Share

  426. SAIA F
    Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
    Catheter Cardiovasc Interv. 2021;98:1413-1414.
    >> Share

  427. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    >> Share

  428. SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
    Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
    >> Share

  429. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    >> Share

    November 2021
  430. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    >> Share

  431. WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
    Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
    Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
    >> Share

  432. HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
    Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
    Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
    >> Share

  433. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    >> Share

  434. GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
    The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
    >> Share

  435. DAS TM, Shin J, Czarny MJ, Nanavati J, et al
    Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
    >> Share

  436. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    >> Share

  437. NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
    Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
    Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
    >> Share

  438. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    >> Share

  439. WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
    The Allegra transcatheter heart valve: Short term results from a multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1204-1209.
    >> Share

  440. ENG MH, Abbas AE, Hahn RT, Lee J, et al
    Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
    Catheter Cardiovasc Interv. 2021;98:1185-1192.
    >> Share

  441. ORVIN K, Perl L, Landes U, Dvir D, et al
    Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
    Catheter Cardiovasc Interv. 2021;98:E862-E869.
    >> Share

  442. DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
    A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
    Catheter Cardiovasc Interv. 2021;98:E847-E854.
    >> Share

  443. RAZUK V, Camaj A, Cao D, Nicolas J, et al
    Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2021;98:E870-E880.
    >> Share

  444. NAZIR S, Ahuja KR, Ariss RW, Hassanein M, et al
    Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
    Catheter Cardiovasc Interv. 2021;98:E839-E846.
    >> Share

  445. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    >> Share

  446. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    >> Share

  447. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    >> Share

  448. REILLY JP, Parikh PB
    Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
    Catheter Cardiovasc Interv. 2021;98:948-949.
    >> Share

  449. ARSLAN F, Gerckens U
    Virtual support for remote proctoring in TAVR during COVID-19.
    Catheter Cardiovasc Interv. 2021;98:E733-E736.
    >> Share

  450. BAGUR R, Jneid H
    Coronary artery access after aortic valve intervention.
    Catheter Cardiovasc Interv. 2021;98:957-958.
    >> Share

  451. KIM JY, Kim SH, Jang SI
    Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;98:923-927.
    >> Share

  452. LE RUZ R, Plessis J, Houeijeh A, Baruteau AE, et al
    Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry.
    Catheter Cardiovasc Interv. 2021;98:990-999.
    >> Share

  453. LEE SY, Kim GB, Kim SH, Jang SI, et al
    Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021;98:E724-E732.
    >> Share

  454. KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
    Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
    Catheter Cardiovasc Interv. 2021;98:1006-1019.
    >> Share

  455. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    >> Share

  456. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    >> Share

    October 2021
  457. AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
    Mobility aids predict mortality after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
    >> Share

  458. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    >> Share

  459. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    >> Share

  460. STANOVA V, Rieu R, Cote N, Salaun E, et al
    In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
    >> Share

  461. TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
    Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
    Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
    >> Share

  462. MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
    Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
    >> Share

  463. MUSUMECI G, Annibali G
    Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021;98:774-775.
    >> Share

  464. OKUYA Y, Moussa ID
    Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
    Catheter Cardiovasc Interv. 2021;98:786-787.
    >> Share

  465. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    >> Share

  466. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    >> Share

  467. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    >> Share

  468. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    >> Share

  469. BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
    Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
    Catheter Cardiovasc Interv. 2021;98:756-764.
    >> Share

  470. GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
    Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
    Catheter Cardiovasc Interv. 2021;98:E626-E636.
    >> Share

  471. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    >> Share

    September 2021
  472. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    >> Share

  473. ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
    Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
    >> Share

  474. LEE DU, Han J, Fan GH, Hastie DJ, et al
    The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
    Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
    >> Share

  475. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    >> Share

  476. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    >> Share

  477. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    >> Share

  478. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    >> Share

  479. PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
    Interventional closure of aortomitral perforation after TAVR: A case report.
    Catheter Cardiovasc Interv. 2021;98:E483-E485.
    >> Share

  480. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    >> Share

  481. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    >> Share

  482. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    >> Share

    August 2021
  483. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    >> Share

  484. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    >> Share

  485. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    >> Share

  486. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    >> Share

  487. BELARDI JA, Lamelas PM
    New TAVR item added to cart for large scale clinical testing.
    Catheter Cardiovasc Interv. 2021;98:380-381.
    >> Share

  488. POSTALIAN A, Krajcer Z
    Individualizing risk assessment for conduction system injury after alcohol septal ablation.
    Catheter Cardiovasc Interv. 2021;98:401-402.
    >> Share

  489. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    >> Share

  490. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    >> Share

  491. GRINES CL, Klein AJ, Bauser-Heaton H, Alkhouli M, et al
    Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.
    Catheter Cardiovasc Interv. 2021;98:277-294.
    >> Share

  492. RIMMAUDO F, Angelini G, Condello I
    Thrombocytopenia after TAVI in patients with low body mass index.
    Catheter Cardiovasc Interv. 2021;98:E329-E331.
    >> Share

  493. KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
    Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Catheter Cardiovasc Interv. 2021;98:E262-E274.
    >> Share

  494. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    >> Share

  495. QURESHI WT, Parker M, Walker J, Kakouros N, et al
    Equipment entrapment during redo-TAVR with successful BASILICA procedure.
    Catheter Cardiovasc Interv. 2021;98:E320-E323.
    >> Share

  496. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    >> Share

  497. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    >> Share

  498. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    >> Share

    July 2021
  499. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    >> Share

  500. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    >> Share

  501. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    >> Share

  502. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    >> Share

  503. CILINGIROGLU M, Okutucu S
    TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
    Catheter Cardiovasc Interv. 2021;98:168-169.
    >> Share

  504. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    >> Share

  505. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    >> Share

  506. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    >> Share

  507. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    >> Share

  508. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    >> Share

    June 2021
  509. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    >> Share

  510. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    >> Share

  511. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    >> Share

  512. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    >> Share

  513. GRINES CL, Leach C
    Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
    Catheter Cardiovasc Interv. 2021;97:1367-1368.
    >> Share

  514. COSTELLO BT, Krajcer Z
    Editorial Comments for: "Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis".
    Catheter Cardiovasc Interv. 2021;97:1479-1480.
    >> Share

  515. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    >> Share

  516. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    >> Share

  517. IMAMURA T, Narang N
    Improving clinical outcomes following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:E1053.
    >> Share

    May 2021
  518. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    >> Share

  519. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    >> Share

  520. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    >> Share

  521. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    >> Share

  522. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    >> Share

  523. BELHAJ SOULAMI R, Castro M, Haigron P, Verhoye JP, et al
    Computer-assisted valve in valve in a deteriorated Mosaic valve using a library of bioprostheses.
    Catheter Cardiovasc Interv. 2021;97:E893-E896.
    >> Share

  524. SAAD AM, Kassis N, Gad MM, Abdelfattah O, et al
    Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis.
    Catheter Cardiovasc Interv. 2021;97:1252-1256.
    >> Share

  525. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    >> Share

  526. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    >> Share

  527. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    >> Share

    April 2021
  528. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    >> Share

  529. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    >> Share

  530. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    >> Share

  531. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    >> Share

  532. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    >> Share

  533. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    >> Share

  534. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    >> Share

  535. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    >> Share

  536. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    >> Share

    March 2021
  537. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    >> Share

  538. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    >> Share

  539. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    >> Share

    February 2021
  540. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    >> Share

  541. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    >> Share

  542. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    >> Share

  543. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    >> Share

  544. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    >> Share

  545. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    >> Share

    January 2021
  546. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    >> Share

  547. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    >> Share

  548. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    >> Share

  549. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    >> Share

    December 2020
  550. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    >> Share

  551. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    >> Share

  552. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    >> Share

  553. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    >> Share

    November 2020
  554. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    >> Share

  555. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    >> Share

  556. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    >> Share

  557. BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
    One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
    >> Share

  558. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    >> Share

  559. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    >> Share

  560. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    >> Share

    October 2020
  561. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    >> Share

  562. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    >> Share

    September 2020
  563. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    >> Share

  564. MORITA Y, Endo A, Tanabe K
    Papillary muscle rupture after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
    >> Share

  565. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    >> Share

  566. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    >> Share

  567. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    >> Share

    August 2020
  568. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    >> Share

  569. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    >> Share

  570. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    >> Share

  571. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    >> Share

    July 2020
  572. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    >> Share

  573. RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
    Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
    >> Share

  574. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    >> Share

  575. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    >> Share

  576. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    >> Share

  577. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    >> Share

  578. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    >> Share

    June 2020
  579. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    >> Share

  580. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    >> Share

  581. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    >> Share

  582. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    >> Share

  583. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    >> Share

  584. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    >> Share

    May 2020
  585. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    >> Share

  586. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    >> Share

  587. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    >> Share

    April 2020
  588. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    >> Share

  589. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    >> Share

    February 2020
  590. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    >> Share

    January 2020
  591. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    >> Share

    December 2019
  592. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    >> Share

    November 2019
  593. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016